EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CYP1B1 promotes PARPi-resistance via histone H1.4 interaction and increased chromatin accessibility in ovarian cancer

Yite Xue, Taotao Yin, Shuo Yuan, Lingfang Wang, Hui Lin, Tianzhe Jin, Ruiyi Xu, Jiaxin Gu, Shizhen Shen, Xiaojing Chen, Zhuoye Chen, Ni Sima und 5 weitere

Drug Resistance Updates · 2024-11 · 77 · 101151

DOI: 10.1016/j.drup.2024.101151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-11. Verfasst von Yite Xue und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Zhejiang Key Laboratory of Precision …. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cytochrome P-450 CYP1B1, Drug Resistance, Neoplasm, Chromatin. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technologies Research and Development Program, Key Research and Development Program of Zhejiang Province, Innovative Research Group Project of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCytochrome P-450 CYP1B1Drug Resistance, NeoplasmChromatinPoly(ADP-ribose) Polymerase InhibitorsHistonesPhthalazinesHumansFemaleCell Line, TumorPiperazinesGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Chromatin accessibilityOvarian cancerPAPRi resistanceTargeted therapyTreatment targets

Substanzen

Cytochrome P-450 CYP1B1CYP1B1 protein, humanChromatinPoly(ADP-ribose) Polymerase InhibitorsolaparibHistonesPhthalazinesPiperazines

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospit…
  • Department of Gynecology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China; Zhejiang Provi…

Förderung

  • Key Technologies Research and Development Program
  • Key Research and Development Program of Zhejiang Province
  • Innovative Research Group Project of the National Natural Science Foundation of China

Zitieren

APA

Xue, Y., Yin, T., Yuan, S., Wang, L., Lin, H., Jin, T., Xu, R., Gu, J., Shen, S., Chen, X., Chen, Z., Sima, N., Chen, L., Lu, W., Li, X., Cheng, X., & Wang, H. (2024). CYP1B1 promotes PARPi-resistance via histone H1.4 interaction and increased chromatin accessibility in ovarian cancer. Drug Resistance Updates, 77, 101151. https://doi.org/10.1016/j.drup.2024.101151

Vancouver

Xue Y, Yin T, Yuan S, Wang L, Lin H, Jin T, et al. CYP1B1 promotes PARPi-resistance via histone H1.4 interaction and increased chromatin accessibility in ovarian cancer. Drug Resistance Updates. 2024;77:101151. doi:10.1016/j.drup.2024.101151

BibTeX
@article{Xue2024,
  author = {Xue, Yite and Yin, Taotao and Yuan, Shuo and Wang, Lingfang and Lin, Hui and Jin, Tianzhe and Xu, Ruiyi and Gu, Jiaxin and Shen, Shizhen and Chen, Xiaojing and Chen, Zhuoye and Sima, Ni and Chen, Lifeng and Lu, Weiguo and Li, Xiao and Cheng, Xiaodong and Wang, Hui},
  title = {CYP1B1 promotes PARPi-resistance via histone H1.4 interaction and increased chromatin accessibility in ovarian cancer},
  journal = {Drug Resistance Updates},
  year = {2024},
  volume = {77},
  pages = {101151},
  doi = {10.1016/j.drup.2024.101151}
}
Kostenlos starten →